Results 101 to 110 of about 557,300 (331)

Clinical and pathogenic bacteria analysis of 1003 children with urinary tract infection in Wuxi

open access: yesLinchuang shenzangbing zazhi, 2020
Objective To investigate the clinical features, common pathogens and their drug resistance in children with urinary tract infection in Wuxi area. Methods The clinical and urinary bacteria culture test and drug susceptibility test results of 1 003 ...
YAO Yao   +13 more
doaj  

Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML

open access: yes
American Journal of Hematology, EarlyView.
Nia Choi   +11 more
wiley   +1 more source

Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis

open access: yesAnnals of Neurology, EarlyView.
Objective Elezanumab is a monoclonal antibody that binds repulsive guidance molecule a (RGMa), an inhibitor of central nervous system regeneration after inflammation or injury. The aim was to assess the safety and efficacy of elezanumab in relapsing and progressive forms of multiple sclerosis (MS).
Bruce A.C. Cree   +6 more
wiley   +1 more source

Association between Observance of Diaper Hygiene and Urinary Tract Infection in Children Under Three Years of Age

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2019
Background and Objectives: Urinary tract infection is one of the most common diseases of the urinary tract and is one of the common infections in infants and children.
Fariba Parvizi   +2 more
doaj  

Urinary Tract Infection: An Overview of the Infection and the Associated Risk Factors

open access: yes, 2014
Urinary tract infection (UTI) is a common bacterial infection known to affect the different parts of the urinary tract and the occurrence is found in both males and females.
R. Vasudevan
semanticscholar   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

open access: yesAnnals of Neurology, EarlyView.
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam   +29 more
wiley   +1 more source

A case of urinary tract infection caused by Raoultella planticola after a urodynamic study

open access: yesBrazilian Journal of Infectious Diseases, 2017
Here we report the case of a patient who developed urinary tract infection after a urodynamic study. The causative agent was Raoultella planticola, a rare opportunistic pathogen that usually invades immunocompromised patients.
Murat Tuğcu   +4 more
doaj  

Extracellular Vesicles in Calcium Oxalate Nephrolithiasis: Emerging Biomarkers and Therapeutic Potential

open access: yesAdvanced NanoBiomed Research, EarlyView.
Kidney stones cause significant pain and healthcare costs. Current prediction, diagnosis, and treatment options are limited. Extracellular vesicles (EVs), rich in proteins, lipids, and nucleic acids, offer a promising solution. This review explores the roles of EVs in kidney stone management, highlighting their potential as biomarkers and therapeutic ...
Wang Zhu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy